GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating Cash Flow | -53.18M | -48.75M | -80.39M | -57.94M | |
| Depreciation & Amort | 3.41M | 3.32M | 3.27M | 3.22M | |
| Capital Expenditure | -751.00K | -154.00K | -3.78M | -933.00K | |
| Free Cash Flow | -53.93M | -48.91M | -84.17M | -58.88M | |
| Investing Cash Flow | 75.53M | -17.07M | -259.93M | 33.31M | |
| Financing Cash Flow | 20.56M | -263.00K | 378.89M | -579.00K |
Revenue CAGR
-10.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-12.6%